)
Hans Gaus
Director, Structural Biology,
Ionis Pharmaceuticals
Hans is heading activities for bioanalytical method development at Ionis Pharmaceuticals since 2005 to support various research programs. These include antisense oligonucleotides, siRNAs and microRNAs. His main focus is to establish methods for identification and quantitation of oligonucleotides and their metabolites from cells and tissues. From 2000 to 2005 he was a member of the ADQC department, where he introduced mass spectrometry-based techniques for quality control of oligonucleotides and their starting materials. He received his Ph.D. from the University of Tuebingen (Germany) for his work on capillary electrophoresis and hyphenating techniques to mass spectrometry in 1994.